<VariationArchive VariationID="12838" VariationName="NG_016202.2:g.(105169_105646)_(109769_110365)del" VariationType="Deletion" Accession="VCV000012838" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-01-26" DateCreated="2018-04-28" MostRecentSubmission="2022-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="27877" VariationID="12838">
      <GeneList>
        <Gene Symbol="SPTB" FullName="spectrin beta, erythrocytic" GeneID="6710" HGNC_ID="HGNC:11274" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>14q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="64746283" stop="64879907" display_start="64746283" display_stop="64879907" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="65213000" stop="65289865" display_start="65213000" display_stop="65289865" Strand="-" />
          </Location>
          <OMIM>182870</OMIM>
        </Gene>
      </GeneList>
      <Name>NG_016202.2:g.(105169_105646)_(109769_110365)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>14q22-q23.2</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>spectrin Durham</Name>
        <Name>EX22-23DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1130" sequenceAccession="LRG_1130">
            <Expression>LRG_1130:g.(105169_105646)_(109769_110365)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016202.2" sequenceAccession="NG_016202" sequenceVersion="2" change="g.(105169_105646)_(109769_110365)del">
            <Expression>NG_016202.2:g.(105169_105646)_(109769_110365)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="182870.0010" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expression for allelic variant 182870.0010 after confirming the exon numbering from the primers published for flanking exons, and consistent with the description summarized in the paper by  Hassoun et al., 1995 (PubMed ):  "...deletion of part of intron 21, exon 22, intron 22, exon 23, and part of intron 23.".</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NG_016202.2:g.(105169_105646)_(109769_110365)del AND Hereditary spherocytosis type 2" Accession="RCV000013689" Version="22">
        <ClassifiedConditionList TraitSetID="3491">
          <ClassifiedCondition DB="MedGen" ID="C2674219">Hereditary spherocytosis type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1992-07-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1992-07-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-04-28" MostRecentSubmission="2022-02-20">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1385736</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">3654760</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3491" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="11072" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Spherocytosis type 2</ElementValue>
                <XRef ID="Spherocytosis+type+2/9331" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary spherocytosis type 2</ElementValue>
                <XRef ID="MONDO:0000913" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPHEROCYTOSIS, TYPE 2, AUTOSOMAL DOMINANT</ElementValue>
                <XRef Type="Allelic variant" ID="182870.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="182870.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="182870.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="182870.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="182870.0015" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SPH2</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HS2</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16149" />
                <XRef ID="16149" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="822" DB="Orphanet" />
              <XRef ID="C2674219" DB="MedGen" />
              <XRef ID="MONDO:0000913" DB="MONDO" />
              <XRef Type="MIM" ID="616649" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="33936" SubmissionDate="2018-04-25" DateLastUpdated="2022-02-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="182870.0010_SPHEROCYTOSIS, TYPE 2, AUTOSOMAL DOMINANT" title="SPTB, EX22-23DEL_SPHEROCYTOSIS, TYPE 2, AUTOSOMAL DOMINANT" />
        <ClinVarAccession Accession="SCV000033936" DateUpdated="2022-02-20" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000033937" DateChanged="2016-04-17" Version="1" />
        </ReplacedList>
        <Classification DateLastEvaluated="1992-07-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an apparent de novo case of hereditary spherocytosis (SPH2; 616649), Hassoun et al. (1995) demonstrated heterozygosity for a deletion of exons 22 and 23 of the SPTB gene. This variant was designated spectrin Durham. Although the mutated gene was efficiently transcribed and its mRNA abundant in reticulocytes, the mutant protein was normally synthesized in erythroid progenitor cells, and the stability of the mutant protein in the cytoplasm of erythroblasts paralleled that of the normal beta-spectrin, the abnormal protein was inefficiently incorporated into the membrane of the erythroblasts. Hassoun et al. (1995) presented evidence that misincorporation into the cell membrane resulted from conformational changes of the beta-spectrin subunit affecting the binding of the abnormal heterodimer to ankyrin. The rate of synthesis of alpha-spectrin is 3 times that of beta-spectrin, and therefore the availability of beta-spectrin determines the rate of assembly of the spectrin heterodimers on the membrane (Hanspal and Palek, 1987, Hanspal et al., 1992). No mutations of alpha-spectrin had been reported as the cause of hereditary spherocytosis. Mutations in band 3 (109270) and particularly in ankyrin (612641) had previously been described in dominantly inherited spherocytosis. One previous example of a heterozygous beta-spectrin mutation, spectrin Kissimmee, had been described (182870.0007).</Attribute>
              <Citation>
                <CitationText>Hassoun, H., Vassiliadis, J. N., Murray, J., Yi, S. J., Hanspal, M., Ware, R. E., Winter, S. S., Chiou, S.-S., Palek, J. Molecular basis of spectrin deficiency in beta spectrin Durham: a deletion within beta spectrin adjacent to the ankyrin-binding site precludes spectrin attachment to the membrane in hereditary spherocytosis. J. Clin. Invest. 96: 2623-2629, 1995.</CitationText>
              </Citation>
              <Citation>
                <CitationText>Hanspal, M., Palek, J. Synthesis and assembly of membrane skeletal proteins in mammalian red cell precursors. J. Cell Biol. 105: 1417-1424, 1987.</CitationText>
              </Citation>
              <Citation>
                <CitationText>Hanspal, M., Hanspal, J. S., Kalraiya, R., Liu, S. C., Sahr, K. E., Howard, D., Palek, J. Asynchronous synthesis of membrane skeletal proteins during terminal maturation of murine erythroblasts. Blood 80: 530-539, 1992.</CitationText>
              </Citation>
              <XRef DB="OMIM" ID="616649" Type="MIM" />
              <XRef DB="OMIM" ID="109270" Type="MIM" />
              <XRef DB="OMIM" ID="612641" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPTB" />
          </GeneList>
          <Name>SPTB, EX22-23DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX22-23DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="182870.0010" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SPHEROCYTOSIS, TYPE 2, AUTOSOMAL DOMINANT</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="33936" TraitType="Disease" MappingType="Name" MappingValue="SPHEROCYTOSIS, TYPE 2, AUTOSOMAL DOMINANT" MappingRef="Preferred">
        <MedGen CUI="C2674219" Name="Hereditary spherocytosis type 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

